Beschreibung
The incidence of Type 1 Diabetes Mellitus (T1DM) has been increasing rapidly worldwide, while the current standard therapy - exogenous insulin supply - is considered unsustainable and highly associated with poor glycemic control that may lead to a life-threatening condition. On the other hand, cellular-based therapy including either islet cell or stem cell transplantation has been recently developed, making it pertinent to compare the effectiveness between the two alternative treatments. The aim of this systematic review is to compare the safety and effectiveness between islet cell transplantation and stem cell transplantation for future practice change.
Autorenporträt
A.I.Sugianto is a 22-year-old Medical Doctor candidate with Bachelor of Medical Science degree from the University of Melbourne.She was one of the 300 young brightest scientists by MOE of UK in 2013. She was also the former Ambassador for HPAIR in 2014. She was involved in breast cancer research, before decided to focus on cellular transplantation.
Herstellerkennzeichnung:
OmniScriptum SRL
Str. Armeneasca 28/1, office 1
2012 Chisinau
MD
E-Mail: info@omniscriptum.com
